Common clinical features of GPD1-associated patients are hepatic steatosis (100%, 19/19), hepatomegaly (100%, 18/18), hypertriglyceridemia (95%, 18/19), and hypohepatia (elevated liver transaminases) (95%, 18/19). The gene discussed is GPD1; the disease is fatty liver disease.